Europe Bevacizumab Biosimilar Market Research Report Forecast 2017 to 2022

November 2017 | 129 pages | ID: E7BAE109C79EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Bevacizumab Biosimilar Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Bevacizumab Biosimilar industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bevacizumab Biosimilar market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Bevacizumab Biosimilar Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Europe Bevacizumab Biosimilar Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Bevacizumab Biosimilar Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 BEVACIZUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Bevacizumab Biosimilar
1.2 Classification of Bevacizumab Biosimilar
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Bevacizumab Biosimilar
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Bevacizumab Biosimilar Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Bevacizumab Biosimilar (2012-2022)
  1.5.1 Europe Bevacizumab Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 Europe Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON BEVACIZUMAB BIOSIMILAR INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 BEVACIZUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

3.1 Bevacizumab Biosimilar Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Bevacizumab Biosimilar Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE BEVACIZUMAB BIOSIMILAR MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Bevacizumab Biosimilar Market Competition by Manufacturers
  5.1.1 Europe Bevacizumab Biosimilar Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Bevacizumab Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Bevacizumab Biosimilar (Volume and Value) by Type
  5.2.1 Europe Bevacizumab Biosimilar Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
5.3 Europe Bevacizumab Biosimilar (Volume and Value) by Countries
  5.3.1 Europe Bevacizumab Biosimilar Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Bevacizumab Biosimilar Revenue and Market Share by Countries (2012-2017)
5.4 Europe Bevacizumab Biosimilar (Volume) by Application

6 GERMANY BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Bevacizumab Biosimilar Sales and Value (2012-2017)
  6.1.1 Germany Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  6.1.2 Germany Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Bevacizumab Biosimilar Sales Price Trend (2012-2017)
6.2 Germany Bevacizumab Biosimilar Sales and Market Share by Manufacturers
6.3 Germany Bevacizumab Biosimilar Sales and Market Share by Type
6.4 Germany Bevacizumab Biosimilar Sales and Market Share by Application

7 FRANCE BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 France Bevacizumab Biosimilar Sales and Value (2012-2017)
  7.1.1 France Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  7.1.2 France Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  7.1.3 France Bevacizumab Biosimilar Sales Price Trend (2012-2017)
7.2 France Bevacizumab Biosimilar Sales and Market Share by Manufacturers
7.3 France Bevacizumab Biosimilar Sales and Market Share by Type
7.4 France Bevacizumab Biosimilar Sales and Market Share by Application

8 UK BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 UK Bevacizumab Biosimilar Sales and Value (2012-2017)
  8.1.1 UK Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  8.1.2 UK Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  8.1.3 UK Bevacizumab Biosimilar Sales Price Trend (2012-2017)
8.2 UK Bevacizumab Biosimilar Sales and Market Share by Manufacturers
8.3 UK Bevacizumab Biosimilar Sales and Market Share by Type
8.4 UK Bevacizumab Biosimilar Sales and Market Share by Application

9 RUSSIA BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Bevacizumab Biosimilar Sales and Value (2012-2017)
  9.1.1 Russia Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  9.1.2 Russia Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Bevacizumab Biosimilar Sales Price Trend (2012-2017)
9.2 Russia Bevacizumab Biosimilar Sales and Market Share by Manufacturers
9.3 Russia Bevacizumab Biosimilar Sales and Market Share by Type
9.4 Russia Bevacizumab Biosimilar Sales and Market Share by Application

10 ITALY BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Bevacizumab Biosimilar Sales and Value (2012-2017)
  10.1.1 Italy Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  10.1.2 Italy Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Bevacizumab Biosimilar Sales Price Trend (2012-2017)
10.2 Italy Bevacizumab Biosimilar Sales and Market Share by Manufacturers
10.3 Italy Bevacizumab Biosimilar Sales and Market Share by Type
10.4 Italy Bevacizumab Biosimilar Sales and Market Share by Application

11 SPAIN BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Bevacizumab Biosimilar Sales and Value (2012-2017)
  11.1.1 Spain Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  11.1.2 Spain Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Bevacizumab Biosimilar Sales Price Trend (2012-2017)
11.2 Spain Bevacizumab Biosimilar Sales and Market Share by Manufacturers
11.3 Spain Bevacizumab Biosimilar Sales and Market Share by Type
11.4 Spain Bevacizumab Biosimilar Sales and Market Share by Application

12 BENELUX BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Bevacizumab Biosimilar Sales and Value (2012-2017)
  12.1.1 Benelux Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Bevacizumab Biosimilar Sales Price Trend (2012-2017)
12.2 Benelux Bevacizumab Biosimilar Sales and Market Share by Manufacturers
12.3 Benelux Bevacizumab Biosimilar Sales and Market Share by Type
12.4 Benelux Bevacizumab Biosimilar Sales and Market Share by Application

13 EUROPE BEVACIZUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Allergan
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Alnylam Pharmaceuticals
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Amgen
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Angstrom Pharmaceuticals
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Acceleron Pharma
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Biocon
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Bionomics
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 CASI Pharmaceuticals
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE BEVACIZUMAB BIOSIMILAR MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Bevacizumab Biosimilar Market Forecast by Type (2017-2022)
15.9 Europe Bevacizumab Biosimilar Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab Biosimilar
Table Classification of Bevacizumab Biosimilar
Figure Europe Sales Market Share of Bevacizumab Biosimilar by Type in 2016
Table Application of Bevacizumab Biosimilar
Figure Europe Sales Market Share of Bevacizumab Biosimilar by Application in 2016
Figure Germany Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure France Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure UK Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Russia Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Italy Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Spain Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Benelux Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Europe Bevacizumab Biosimilar Sales and Growth Rate (2012-2022)
Figure Europe Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Table Europe Bevacizumab Biosimilar Sales of Key Manufacturers (2015 and 2016)
Table Europe Bevacizumab Biosimilar Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Biosimilar Sales Share by Manufacturers
Figure 2016 Bevacizumab Biosimilar Sales Share by Manufacturers
Table Europe Bevacizumab Biosimilar Revenue by Manufacturers (2015 and 2016)
Table Europe Bevacizumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Bevacizumab Biosimilar Revenue Share by Manufacturers
Table 2016 Europe Bevacizumab Biosimilar Revenue Share by Manufacturers
Table Europe Bevacizumab Biosimilar Sales and Market Share by Type (2012-2017)
Table Europe Bevacizumab Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure Europe Bevacizumab Biosimilar Sales Growth Rate by Type (2012-2017)
Table Europe Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
Table Europe Bevacizumab Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure Europe Bevacizumab Biosimilar Revenue Growth Rate by Type (2012-2017)
Table Europe Bevacizumab Biosimilar Sales and Market Share by Countries (2012-2017)
Table Europe Bevacizumab Biosimilar Sales Share by Countries (2012-2017)
Figure Sales Market Share of Bevacizumab Biosimilar by Countries (2012-2017)
Table Europe Bevacizumab Biosimilar Revenue and Market Share by Countries (2012-2017)
Table Europe Bevacizumab Biosimilar Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Bevacizumab Biosimilar by Countries (2012-2017)
Table Europe Bevacizumab Biosimilar Sales and Market Share by Application (2012-2017)
Table Europe Bevacizumab Biosimilar Sales Share by Application (2012-2017)
Figure Sales Market Share of Bevacizumab Biosimilar by Application (2012-2017)
Figure Germany Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure Germany Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure Germany Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table Germany Bevacizumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Germany Bevacizumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Germany Bevacizumab Biosimilar Sales by Type (2015 and 2016)
Table Germany Bevacizumab Biosimilar Market Share by Type (2015 and 2016)
Table Germany Bevacizumab Biosimilar Sales by Application (2015 and 2016)
Table Germany Bevacizumab Biosimilar Market Share by Application (2015 and 2016)
Figure France Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure France Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure France Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table France Bevacizumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table France Bevacizumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table France Bevacizumab Biosimilar Sales by Type (2015 and 2016)
Table France Bevacizumab Biosimilar Market Share by Type (2015 and 2016)
Table France Bevacizumab Biosimilar Sales by Application (2015 and 2016)
Table France Bevacizumab Biosimilar Market Share by Application (2015 and 2016)
Figure UK Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure UK Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure UK Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table UK Bevacizumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table UK Bevacizumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table UK Bevacizumab Biosimilar Sales by Type (2015 and 2016)
Table UK Bevacizumab Biosimilar Market Share by Type (2015 and 2016)
Table UK Bevacizumab Biosimilar Sales by Application (2015 and 2016)
Table UK Bevacizumab Biosimilar Market Share by Application (2015 and 2016)
Figure Russia Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure Russia Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure Russia Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table Russia Bevacizumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Russia Bevacizumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Russia Bevacizumab Biosimilar Sales by Type (2015 and 2016)
Table Russia Bevacizumab Biosimilar Market Share by Type (2015 and 2016)
Table Russia Bevacizumab Biosimilar Sales by Application (2015 and 2016)
Table Russia Bevacizumab Biosimilar Market Share by Application (2015 and 2016)
Figure Italy Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure Italy Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure Italy Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table Italy Bevacizumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Italy Bevacizumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Italy Bevacizumab Biosimilar Sales by Type (2015 and 2016)
Table Italy Bevacizumab Biosimilar Market Share by Type (2015 and 2016)
Table Italy Bevacizumab Biosimilar Sales by Application (2015 and 2016)
Table Italy Bevacizumab Biosimilar Market Share by Application (2015 and 2016)
Figure Spain Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure Spain Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure Spain Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table Spain Bevacizumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Spain Bevacizumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Spain Bevacizumab Biosimilar Sales by Type (2015 and 2016)
Table Spain Bevacizumab Biosimilar Market Share by Type (2015 and 2016)
Table Spain Bevacizumab Biosimilar Sales by Application (2015 and 2016)
Table Spain Bevacizumab Biosimilar Market Share by Application (2015 and 2016)
Figure Benelux Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure Benelux Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure Benelux Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table Benelux Bevacizumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Benelux Bevacizumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Benelux Bevacizumab Biosimilar Sales by Type (2015 and 2016)
Table Benelux Bevacizumab Biosimilar Market Share by Type (2015 and 2016)
Table Benelux Bevacizumab Biosimilar Sales by Application (2015 and 2016)
Table Benelux Bevacizumab Biosimilar Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Bevacizumab Biosimilar Sales Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab Biosimilar
Figure Manufacturing Process Analysis of Bevacizumab Biosimilar
Figure Bevacizumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
Table Major Buyers of Bevacizumab Biosimilar
Table Distributors/Traders List
Figure Germany Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Germany Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure France Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure France Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure UK Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure UK Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Russia Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Italy Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Spain Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Table Europe Bevacizumab Biosimilar Sales Forecast by Type (2017-2022)
Table Europe Bevacizumab Biosimilar Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals